Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05516225 · ClinicalTrials.gov registry record · Phase 1
Safety Study of Human Milk Oligosaccharides in Healthy Adults
A Phase 1 study, sponsored by Prolacta Bioscience.
- Completed
- Registry status
- Phase 1
- Development phase
- 32
- Enrollment target
NCT05516225 is a Phase 1 study that has completed, run by Prolacta Bioscience. The registered enrollment target is 32 participants.
The verdict
NCT05516225, a Phase 1 study, has completed, sponsored by Prolacta Bioscience.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 32 participants
- Enrollment target
Study Summary
First-in-human phase 1 study conducted in healthy adult male and female volunteers to determine the safety and tolerability of increasing doses of PBCLN-003, which are concentrated human milk oligosaccharides (HMO).
Interventions
- DRUG PBCLN-003
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2016-09-29 |
| Est. Completion | 2017-02-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05516225
The ClinicalTrials.gov registry entry for NCT05516225 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prolacta Bioscience, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PBCLN-003 is the first listed.
NCT05516225 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05516225 about?
NCT05516225 is a clinical study titled "Safety Study of Human Milk Oligosaccharides in Healthy Adults". First-in-human phase 1 study conducted in healthy adult male and female volunteers to determine the safety and tolerability of increasing doses of PBCLN-003, which are concentrated human milk oligosaccharides (HMO).
What is the current status of trial NCT05516225?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 32 participants. The study started on 2016-09-29. Estimated completion is 2017-02-13.
What interventions are being tested in trial NCT05516225?
The interventions under investigation include: PBCLN-003 (DRUG).
Who is sponsoring clinical trial NCT05516225?
This trial is sponsored by Prolacta Bioscience, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.